The shift from empirical discovery to rational, platform-enabled design is unlocking opportunities to develop safer, more effective vaccines for today’s most challenging pathogens. As developers seek technologies that extend antigenic coverage, improve tolerability, and increase manufacturability, outer-membrane vesicles (OMVs) are reemerging as a solution.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Miki
Contact Miki, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack